Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Which blood thinner works best for APS patients? new study aims to find out

NCT ID NCT07372170

First seen Jan 31, 2026 · Last updated May 20, 2026 · Updated 18 times

Summary

This study looks at two types of blood thinners (DOACs and VKAs) to see which is better at preventing repeat blood clots in people with a low-risk form of antiphospholipid syndrome (APS). APS is an autoimmune condition that raises the risk of dangerous clots. The study will follow 600 adults already taking one of these medications as part of their normal care, tracking how many have another clot or a bleeding event. The goal is to provide clearer guidance on which treatment is safest and most effective for this specific group.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANTIPHOSPHOLIPID SYNDROME (APS) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • Hospital Universitario Infanta Leonor

    RECRUITING

    Madrid, Madrid, 28031, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hospital Universitario Infanta Sofía

    RECRUITING

    Madrid, Madrid, Spain

    Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.